A New Method for Recombinant Adeno-associated Virus Vector Delivery to Murine Diaphragm
Authors:
Open Access
- 1 March 2004
- journal article
- method
- Published by Elsevier in Molecular Therapy
- Vol. 9 (3) , 458-463
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectorsNature Biotechnology, 2003
- In vitro selection of viral vectors with modified tropism: the adeno-associated virus displayMolecular Therapy, 2003
- Receptor targeting of adeno-associated virus vectorsGene Therapy, 2003
- RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanismMolecular Therapy, 2003
- Conjugate-Based Targeting of Recombinant Adeno-Associated Virus Type 2 Vectors by Using Avidin-Linked LigandsJournal of Virology, 2002
- Insertional Mutagenesis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors Targeted to Alternative Cell-Surface ReceptorsHuman Gene Therapy, 2001
- Transfer of Full-Length Dmd to the Diaphragm Muscle of Dmdmdx/mdx Mice through Systemic Administration of Plasmid DNAMolecular Therapy, 2001
- Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered TropismJournal of Virology, 2000
- Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheresGene Therapy, 1999
- Respiratory muscles as a target for adenovirus-mediated gene therapyEuropean Respiratory Journal, 1998